0
Article |

Further Warnings From Australia Concerning Intraspinal Steroids

Dewey A. Nelson, MD
Arch Neurol. 1991;48(3):259-259. doi:10.1001/archneur.1991.00530150027009
Text Size: A A A
Published online

To the Editor.  —There have been numerous warnings in various medical journals concerning the therapeutic use of methylprednisolone acetate (Depo-Medrol, Upjohn, Kalamazoo, Mich) by intraspinal injection.1-19 Goldstein et al1 were the first to publish complications in 1970. There followed reports of additional complications by Nelson et al,2-6 Bernat et al,7 Nelson,8-10 Roche,11 Sekel,12 Kepes and Duncalf,13 and Nelson.14-19 Bernat et al7 demonstrated how this steroid compound entered the subdural space, then formed a "second sac," following which it migrated intracranially. Though the intrathecal use of methylprednisolone acetate virtually terminated by 1980,14 the epidural use by anesthesiologists in pain clinics gave rise to even more controversy than did its intrathecal therapy.11-19 Two studies from Australia described 82% to 100% roentgenographically proved arachnoiditis (even from single injections) that resulted from intrathecal use,11 as well as sterile meningitis, pachymeningitis with

REFERENCES

Goldstein NP, McKenzie BF, McGuckim WF, Mattox VR.  Experimental intrathecal administration of methylprednisolone acetate in multiple sclerosis . Trans Am Neurol Assoc . 1970;;95:243-244.
Nelson DA, Vates TS. Thomas RB. Complications from intrathecal steroids in the treatment of multiple sclerosis. By invitation, presented before National Advisory Board, National Multiple Sclerosis Society, New York, NY, December 5, 1971.
Nelson DA, Vates TS, Thomas JR.  Complications from intrathecal steroid therapy in patients with multiple sclerosis . Neurology . 1972;;22:454.
Nelson DA, Vates TS, Thomas RB.  Complications from intrathecal steroid therapy in patients with multiple sclerosis . Acta Neurol Scand . 1973;;49:176-188.
Nelson DA.  Arachnoiditis from intrathecally given corticosteroids in the treatment of multiple sclerosis . Arch Neurol . 1976;;33:373.
Nelson DA. Presentation by Bernat JL, Sadowsky CH, Vincent FM, Nordgren RE, Margolis G. Sclerosing spinal pachymeningitis associated with intrathecal methylprednisolone acetate administration for multiple sclerosis (Discussion by Invitation), American Academy of Neurology 28th Annual Meeting, Toronto, Ontario, April 29, 1976.
Bernat JL, Sadowsky CH, Vincent FM, Nordgren RE, Margolis G.  A complication of intrathecal administration of Depo-Medrol for multiple sclerosis . J Neurol Neurosurg Psychiatry . 1976;;39:1124-1128.
Nelson DA. Depo-Medrol Intrathecally. Guest Lecturer. Meeting of All Members of the Medical Staff and House Staff. Episcopal Hospital, Philadelphia, Pa, February 17, 1977.
Nelson DA, Abel R, Bernat JL.  Complications from methylprednisolone acetate (Depo-Medrol) when injected into the orbit, subarachnoid or subdural spaces . Del Med J . 1977;;49:331-343.
Nelson DA.  Methylprednisolone acetate . Arch Neurol . 1979;;36:661-662.
Roche J.  Steroid-induced arachnoiditis . Med J Aust . 1984;;140:281-284.
Sekel R.  Epidural Depo-Medrol revisited . Med J Aust . 1984;;140:688.
Kepes ER, Duncalf D.  Treatment of backache with spinal injections of local anesthetics, spinal and systemic steroids: review . Pain . 1985;;22:33-47.
Nelson DA.  Dangers from methylprednisolone acetate therapy by intraspinal injection . Arch Neurol . 1988;;45:805-806.
Nelson DA.  Safety of intrathecal steroids in multiple sclerosis . Arch Neurol . 1989;;46:718-719.
Nelson DA.  Perceived dangers from intraspinal steroid injections . Arch Neurol . 1989;;46:719-721.
Nelson DA.  Dangers from methylprednisolone acetate therapy by intraspinal injection . Arch Neurol . 1989;;46:721-722.
Nelson DA.  Pain in multiple sclerosis . Neurology . 1989;;39:1000-1001.
Nelson DA.  Dangers from intraspinal steroid injections . Arch Neurol . 1990;;47:255.

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Goldstein NP, McKenzie BF, McGuckim WF, Mattox VR.  Experimental intrathecal administration of methylprednisolone acetate in multiple sclerosis . Trans Am Neurol Assoc . 1970;;95:243-244.
Nelson DA, Vates TS. Thomas RB. Complications from intrathecal steroids in the treatment of multiple sclerosis. By invitation, presented before National Advisory Board, National Multiple Sclerosis Society, New York, NY, December 5, 1971.
Nelson DA, Vates TS, Thomas JR.  Complications from intrathecal steroid therapy in patients with multiple sclerosis . Neurology . 1972;;22:454.
Nelson DA, Vates TS, Thomas RB.  Complications from intrathecal steroid therapy in patients with multiple sclerosis . Acta Neurol Scand . 1973;;49:176-188.
Nelson DA.  Arachnoiditis from intrathecally given corticosteroids in the treatment of multiple sclerosis . Arch Neurol . 1976;;33:373.
Nelson DA. Presentation by Bernat JL, Sadowsky CH, Vincent FM, Nordgren RE, Margolis G. Sclerosing spinal pachymeningitis associated with intrathecal methylprednisolone acetate administration for multiple sclerosis (Discussion by Invitation), American Academy of Neurology 28th Annual Meeting, Toronto, Ontario, April 29, 1976.
Bernat JL, Sadowsky CH, Vincent FM, Nordgren RE, Margolis G.  A complication of intrathecal administration of Depo-Medrol for multiple sclerosis . J Neurol Neurosurg Psychiatry . 1976;;39:1124-1128.
Nelson DA. Depo-Medrol Intrathecally. Guest Lecturer. Meeting of All Members of the Medical Staff and House Staff. Episcopal Hospital, Philadelphia, Pa, February 17, 1977.
Nelson DA, Abel R, Bernat JL.  Complications from methylprednisolone acetate (Depo-Medrol) when injected into the orbit, subarachnoid or subdural spaces . Del Med J . 1977;;49:331-343.
Nelson DA.  Methylprednisolone acetate . Arch Neurol . 1979;;36:661-662.
Roche J.  Steroid-induced arachnoiditis . Med J Aust . 1984;;140:281-284.
Sekel R.  Epidural Depo-Medrol revisited . Med J Aust . 1984;;140:688.
Kepes ER, Duncalf D.  Treatment of backache with spinal injections of local anesthetics, spinal and systemic steroids: review . Pain . 1985;;22:33-47.
Nelson DA.  Dangers from methylprednisolone acetate therapy by intraspinal injection . Arch Neurol . 1988;;45:805-806.
Nelson DA.  Safety of intrathecal steroids in multiple sclerosis . Arch Neurol . 1989;;46:718-719.
Nelson DA.  Perceived dangers from intraspinal steroid injections . Arch Neurol . 1989;;46:719-721.
Nelson DA.  Dangers from methylprednisolone acetate therapy by intraspinal injection . Arch Neurol . 1989;;46:721-722.
Nelson DA.  Pain in multiple sclerosis . Neurology . 1989;;39:1000-1001.
Nelson DA.  Dangers from intraspinal steroid injections . Arch Neurol . 1990;;47:255.

Correspondence

CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.